These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25296874)

  • 1. [Cognitive impairment in multiple sclerosis].
    Ochi H
    Brain Nerve; 2014 Oct; 66(10):1201-9. PubMed ID: 25296874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognitive impairment in multiple sclerosis].
    Karlińska I; Selmaj K
    Neurol Neurochir Pol; 2005; 39(2):125-33. PubMed ID: 15871058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis.
    Miller E; Morel A; Redlicka J; Miller I; Saluk J
    Curr Neuropharmacol; 2018; 16(4):475-483. PubMed ID: 29119933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in multiple sclerosis.
    Chiaravalloti ND; DeLuca J
    Lancet Neurol; 2008 Dec; 7(12):1139-51. PubMed ID: 19007738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
    Benedict RH; Carone DA; Bakshi R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):36S-45S. PubMed ID: 15228758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognitive impairment].
    Reuter F; Audoin B; Rico A; Malikova I; Ranjeva JP; Pelletier J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.
    Benedict RH; Bruce J; Dwyer MG; Weinstock-Guttman B; Tjoa C; Tavazzi E; Munschauer FE; Zivadinov R
    Mult Scler; 2007 Jul; 13(6):722-30. PubMed ID: 17613599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive impairment in multiple sclerosis patients].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2004; 126(7-8):204-10. PubMed ID: 15754791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cognitive impairment in patients with multiple sclerosis.
    Patti F
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1679-99. PubMed ID: 22876911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue.
    Lund H; Jønsson A; Andresen J; Rostrup E; Paulson OB; Sørensen PS
    Acta Neurol Scand; 2012 May; 125(5):338-44. PubMed ID: 21793807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
    Rovaris M; Comi G; Filippi M
    J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M
    Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychological and neuropsychological problems in multiple sclerosis].
    Béquet D; Taillia H; Clervoy P; Renard JL; Flocard F
    Bull Acad Natl Med; 2003; 187(4):683-94; discussion 695-7. PubMed ID: 14556476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
    Benedict RH; Hulst HE; Bergsland N; Schoonheim MM; Dwyer MG; Weinstock-Guttman B; Geurts JJ; Zivadinov R
    Mult Scler; 2013 Oct; 19(11):1478-84. PubMed ID: 23459570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.
    Bagert B; Camplair P; Bourdette D
    CNS Drugs; 2002; 16(7):445-55. PubMed ID: 12056920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J; Montalban X
    J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.